Related Experiment Video
Updated: Aug 15, 2026

In Utero Intraventricular Injection and Electroporation of E16 Rat Embryos
Published on: July 19, 2007
Effects of ergothioneine on diabetic embryopathy in pregnant rats
M V Guijarro1, A Indart, O I Aruoma
1Facultad de Ciencias Experimentales y Técnicas, Universidad de San Pablo CEU, PO Box 67, 28660 Boadilla del Monte, Madrid, Spain.
Abstract:
The natural antioxidant ergothioneine (2-mercaptohistidine trimethylbetaine) is a fungal metabolite and found in most plant and animal tissues. The effect of ergothioneine on diabetic embryopathy in rats was assessed. Supplementation of diabetic pregnant rats with L-ergothioneine (1.147 mg/kg body weight) daily for the first 11.5 days of pregnancy reduced the rate of embryo malformations, to values similar to the non-diabetic animals. The ergothioneine had no effect on the plasma glucose levels, both in diabetic and control animals. We conclude that the inhibition of the glucose-mediated free radical dependent embryo malformation by ergothioneine is an important antioxidant prophylactic mechanism, which when combined with vitamin E could benefit the management of diabetic embryopathy.

